These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
11-1986657
|
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
|
|
|
55 CHARLES LINDBERGH BLVD., MITCHEL FIELD, N.Y.
|
11553
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Large accelerated filer
☐
|
Accelerated filer
☐
|
|
Non-accelerated filer
☐
(Do not check if a smaller reporting company)
|
Smaller Reporting Company
☒
|
|
Emerging growth company
☐
|
|
|
Part I. Financial Information:
|
Page No.
|
|
|
|
|
|
|
|
|
|
|
3
|
|
|
|
|
|
4
|
|
|
|
|
|
5
|
|
|
6
|
|
|
|
|
|
7-14
|
|
|
|
|
|
15-21
|
|
|
|
|
|
21
|
|
|
|
|
|
21
|
|
|
|
|
|
Part II. Other Information:
|
|
|
|
|
|
22
|
|
|
|
|
|
23
|
|
|
|
|
|
|
October 31,
|
April 30,
|
||||||
|
|
2017
|
2017
|
||||||
|
|
(UNAUDITED)
|
|||||||
|
ASSETS:
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$
|
11,015
|
$
|
2,163
|
||||
|
Marketable securities
|
1,395
|
7,815
|
||||||
|
Accounts receivable, net of allowance for doubtful accounts
of $187 at October 31, 2017 and at April 30, 2017
|
7,071
|
10,986
|
||||||
|
Costs and estimated earnings in excess of billings, net
|
5,949
|
7,964
|
||||||
|
Inventories, net
|
31,210
|
29,051
|
||||||
|
Prepaid income taxes
|
3,478
|
2,606
|
||||||
|
Prepaid expenses and other
|
1,242
|
1,105
|
||||||
|
Current assets of discontinued operations
|
8,157
|
8,165
|
||||||
|
Total current assets
|
69,517
|
69,855
|
||||||
|
Property, plant and equipment, at cost, net of
accumulated depreciation and amortization
|
14,349
|
14,813
|
||||||
|
Deferred income taxes
|
11,794
|
11,902
|
||||||
|
Goodwill and other intangible assets
|
617
|
617
|
||||||
|
Cash surrender value of life insurance and cash held in trust
|
13,694
|
13,376
|
||||||
|
Other assets
|
2,169
|
2,187
|
||||||
|
Non-current assets of discontinued operations
|
562
|
569
|
||||||
|
Total assets
|
$
|
112,702
|
$
|
113,319
|
||||
|
|
||||||||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY:
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable - trade
|
$
|
2,694
|
$
|
2,437
|
||||
|
Accrued liabilities
|
2,907
|
3,425
|
||||||
|
Current liabilities of discontinued operations
|
1,978
|
2,249
|
||||||
|
Total current liabilities
|
7,579
|
8,111
|
||||||
|
|
||||||||
|
Deferred compensation
|
13,453
|
13,252
|
||||||
|
Deferred rent and other liabilities
|
1,405
|
1,409
|
||||||
|
Non-current liabilities of discontinued operations
|
1,387
|
1,215
|
||||||
|
Total liabilities
|
23,824
|
23,987
|
||||||
|
Commitments and contingencies
|
||||||||
|
Stockholders’ equity:
|
||||||||
|
Preferred stock - $1.00 par value authorized 600 shares, no shares issued
|
-
|
-
|
||||||
|
Common stock - $1.00 par value; authorized 20,000 shares, 9,164 shares issued and
8,843 outstanding at October 31, 2017; 8,817 outstanding at April 30, 2017
|
9,164
|
9,164
|
||||||
|
Additional paid-in capital
|
56,139
|
55,767
|
||||||
|
Retained earnings
|
22,845
|
23,712
|
||||||
|
|
88,148
|
88,643
|
||||||
|
Common stock reacquired and held in treasury -
at cost (321 shares at October 31, 2017 and 347 shares at April 30, 2017)
|
(1,472
|
)
|
(1,592
|
)
|
||||
|
Accumulated other comprehensive income
|
2,202
|
2,281
|
||||||
|
Total stockholders’ equity
|
88,878
|
89,332
|
||||||
|
Total liabilities and stockholders’ equity
|
$
|
112,702
|
$
|
113,319
|
||||
|
|
2017
|
2016
|
||||||
|
Condensed Consolidated Statements of Income
|
||||||||
|
Revenues
|
$
|
21,360
|
$
|
23,028
|
||||
|
Cost of revenues
|
14,636
|
15,474
|
||||||
|
Gross margin
|
6,724
|
7,554
|
||||||
|
Selling and administrative expenses
|
5,046
|
5,648
|
||||||
|
Research and development expense
|
3,364
|
3,496
|
||||||
|
Operating loss
|
(1,686
|
)
|
(1,590
|
)
|
||||
|
|
||||||||
|
Other income (expense):
|
||||||||
|
Investment income
|
1,167
|
279
|
||||||
|
Interest expense
|
(41
|
)
|
(67
|
)
|
||||
|
Other income, net
|
3
|
1
|
||||||
|
Loss before provision for income taxes
|
(557
|
)
|
(1,377
|
)
|
||||
|
Benefit for income taxes
|
(98
|
)
|
(204
|
)
|
||||
|
Net loss from continuing operations
|
(459
|
)
|
(1,173
|
)
|
||||
|
Loss from discontinued operations, net of tax
|
(408
|
)
|
(557
|
)
|
||||
|
Net loss
|
$
|
(867
|
)
|
$
|
(1,730
|
)
|
||
|
|
||||||||
|
Net loss per common share:
|
||||||||
|
Basic loss from continued operations
|
$
|
(0.05
|
)
|
$
|
(0.14
|
)
|
||
|
Basic loss from discontinued operations
|
(0.05
|
)
|
(0.06
|
)
|
||||
|
Basic loss per share
|
(0.10
|
)
|
(0.20
|
)
|
||||
|
Diluted loss from continued operations
|
(0.05
|
)
|
(0.14
|
)
|
||||
|
Diluted loss from discontinued operations
|
(0.05
|
)
|
(0.06
|
)
|
||||
|
Diluted loss per share
|
$
|
(0.10
|
)
|
$
|
(0.20
|
)
|
||
|
|
||||||||
|
Weighted average shares outstanding:
|
||||||||
|
Basic
|
8,830
|
8,771
|
||||||
|
Diluted
|
8,830
|
8,771
|
||||||
|
|
||||||||
|
|
||||||||
|
Condensed Consolidated Statements of Comprehensive Loss
|
||||||||
|
Net loss
|
$
|
(867
|
)
|
$
|
(1,730
|
)
|
||
|
Other comprehensive loss:
|
||||||||
|
Foreign currency translation adjustment
|
575
|
369
|
||||||
|
Unrealized (loss) gain on marketable securities:
|
||||||||
|
Change in market value of marketable securities before
reclassification, net of tax of ($20) and ($61)
|
37
|
118
|
||||||
|
Reclassification adjustment for realized gains included in
net income, net of tax of $356 in 2017
|
(691
|
)
|
-
|
|||||
|
Total unrealized (loss) gain on marketable securities, net of tax
|
(654
|
)
|
118
|
|||||
|
|
||||||||
|
Total other comprehensive loss (income)
|
(79
|
)
|
487
|
|||||
|
Comprehensive loss
|
$
|
(946
|
)
|
$
|
(1,243
|
)
|
||
|
|
2017
|
2016
|
||||||
|
Condensed Consolidated Statements of Income
|
||||||||
|
Revenues
|
$
|
9,337
|
$
|
11,466
|
||||
|
Cost of revenues
|
7,134
|
7,737
|
||||||
|
Gross margin
|
2,203
|
3,729
|
||||||
|
Selling and administrative expenses
|
2,335
|
2,816
|
||||||
|
Research and development expense
|
1,734
|
2,095
|
||||||
|
Operating loss
|
(1,866
|
)
|
(1,182
|
)
|
||||
|
|
||||||||
|
Other expense:
|
||||||||
|
Investment income
|
13
|
187
|
||||||
|
Interest expense
|
(21
|
)
|
(26
|
)
|
||||
|
Other income, net
|
1
|
-
|
||||||
|
Loss before provision for income taxes
|
(1,873
|
)
|
(1,021
|
)
|
||||
|
Benefit for income taxes
|
(584
|
)
|
(164
|
)
|
||||
|
Net loss from continuing operations
|
(1,289
|
)
|
(857
|
)
|
||||
|
Loss from discontinued operations, net of tax
|
(192
|
)
|
(167
|
)
|
||||
|
Net loss
|
$
|
(1,481
|
)
|
$
|
(1,024
|
)
|
||
|
|
||||||||
|
Net loss per common share:
|
||||||||
|
Basic loss from continued operations
|
$
|
(0.15
|
)
|
$
|
(0.10
|
)
|
||
|
Basic loss from discontinued operations
|
(0.02
|
)
|
(0.02
|
)
|
||||
|
Basic loss per share
|
(0.17
|
)
|
(0.12
|
)
|
||||
|
Diluted loss from continued operations
|
(0.15
|
)
|
(0.10
|
)
|
||||
|
Diluted loss from discontinued operations
|
(0.02
|
)
|
(0.02
|
)
|
||||
|
Diluted loss per share
|
$
|
(0.17
|
)
|
$
|
(0.12
|
)
|
||
|
|
||||||||
|
Weighted average shares outstanding:
|
||||||||
|
Basic
|
8,835
|
8,781
|
||||||
|
Diluted
|
8,835
|
8,781
|
||||||
|
|
||||||||
|
|
||||||||
|
Condensed Consolidated Statements of Comprehensive Loss
|
||||||||
|
Net loss
|
$
|
(1,481
|
)
|
$
|
(1,024
|
)
|
||
|
Other comprehensive income:
|
||||||||
|
Foreign currency translation adjustment
|
260
|
984
|
||||||
|
Unrealized (loss) gain on marketable securities:
|
||||||||
|
Change in market value of marketable securities before
reclassification, net of tax of ($2) and ($161)
|
3
|
(194
|
)
|
|||||
|
Reclassification adjustment for realized gains included in
net income, net of tax of $1 in 2017
|
(2
|
)
|
-
|
|||||
|
Total unrealized (loss) gain on marketable securities, net of tax
|
1
|
(194
|
)
|
|||||
|
|
||||||||
|
Total other comprehensive income
|
261
|
790
|
||||||
|
Comprehensive loss
|
$
|
(1,220
|
)
|
$
|
(234
|
)
|
||
|
|
2017
|
2016
|
||||||
|
Cash flows from operating activities:
|
||||||||
|
Net loss from continuing operations
|
$
|
(459
|
)
|
$
|
(1,173
|
)
|
||
|
Net loss from discontinued operations
|
(408
|
)
|
(557
|
)
|
||||
|
Net loss
|
(867
|
)
|
(1,730
|
)
|
||||
|
Non-cash charges to earnings
|
1,451
|
2,864
|
||||||
|
Net changes in operating assets and liabilities
|
1,631
|
(4,340
|
)
|
|||||
|
Cash provided by (used in) operating activities – continuing operations
|
2,215
|
(3,206
|
)
|
|||||
|
Cash provided by operating activities – discontinued operations
|
614
|
728
|
||||||
|
Net cash provided by (used in) operating activities
|
2,829
|
(2,478
|
)
|
|||||
|
|
||||||||
|
Cash flows from investing activities:
|
||||||||
|
Proceeds on redemption of marketable securities
|
6,477
|
1,000
|
||||||
|
Purchase of fixed assets and other assets
|
(883
|
)
|
(2,413
|
)
|
||||
|
Cash provided by (used in) investing activities – continuing operations
|
5,594
|
(1,413
|
)
|
|||||
|
Cash used in investing activities – discontinued operations
|
(28
|
)
|
(10
|
)
|
||||
|
Net cash provided by (used in) investing activities
|
5,566
|
(1,423
|
)
|
|||||
|
|
||||||||
|
Cash flows from financing activities:
|
||||||||
|
Tax benefit from exercise of stock-based compensation
|
1
|
25
|
||||||
|
Cash provided by financing activities – continuing operations
|
1
|
25
|
||||||
|
Cash used in financing activities – discontinued operations
|
-
|
280
|
||||||
|
Net cash provided by financing activities
|
1
|
305
|
||||||
|
|
||||||||
|
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes
|
8,396
|
(3,596
|
)
|
|||||
|
|
||||||||
|
Effect of exchange rate changes on cash and cash equivalents
|
675
|
1,619
|
||||||
|
|
||||||||
|
Net increase (decrease) in cash and cash equivalents
|
9,071
|
(1,977
|
)
|
|||||
|
|
||||||||
|
Cash and cash equivalents at beginning of period
|
2,738
|
6,082
|
||||||
|
|
||||||||
|
Cash and cash equivalents at end of period
|
11,809
|
4,105
|
||||||
|
|
||||||||
|
Less cash and equivalents of discontinued operations at end of period
|
794
|
344
|
||||||
|
|
||||||||
|
Cash and cash equivalents of continuing operations at end of period
|
$
|
11,015
|
$
|
3,761
|
||||
|
|
||||||||
|
|
||||||||
|
Supplemental disclosures of cash flow information:
|
||||||||
|
Cash paid during the period for:
|
||||||||
|
Interest
|
$
|
41
|
$
|
76
|
||||
|
Income Taxes
|
$
|
325
|
$
|
335
|
||||
|
|
Six months
|
Three months
|
||||||||||||||
|
|
Periods ended October 31,
|
|||||||||||||||
|
|
2017
|
2016
|
2017
|
2016
|
||||||||||||
|
(UNAUDITED)
|
(UNAUDITED)
|
(UNAUDITED)
|
(UNAUDITED)
|
|||||||||||||
|
(In thousands except par value)
|
||||||||||||||||
|
Revenues
|
$
|
1,955
|
$
|
2,294
|
$
|
943
|
$
|
1,448
|
||||||||
|
Cost of Revenues
|
1,390
|
1,621
|
674
|
1,064
|
||||||||||||
|
Gross Margin
|
565
|
673
|
269
|
384
|
||||||||||||
|
Selling and administrative expenses
|
703
|
950
|
346
|
456
|
||||||||||||
|
Research and development expenses
|
268
|
277
|
118
|
94
|
||||||||||||
|
Operating Loss
|
(406
|
)
|
(554
|
)
|
(195
|
)
|
(166
|
)
|
||||||||
|
Other income (expense):
|
||||||||||||||||
|
Investment (loss) income
|
||||||||||||||||
|
Other income (expense), net
|
(3
|
)
|
(3
|
)
|
(2
|
)
|
(2
|
)
|
||||||||
|
Loss before provision for income taxes
|
(409
|
)
|
(557
|
)
|
(197
|
)
|
(168
|
)
|
||||||||
|
Benefit for income taxes
|
1
|
-
|
5
|
-
|
||||||||||||
|
Net Loss
|
$
|
(408
|
)
|
$
|
(557
|
)
|
$
|
(192
|
)
|
$
|
(168
|
)
|
||||
|
|
October 31,
|
April 30,
|
||||||
|
|
2017
|
2017
|
||||||
|
|
||||||||
|
Cash and cash equivalents
|
$
|
794
|
$
|
575
|
||||
|
Accounts receivable, net of allowance for doubtful accounts
|
2,525
|
3,202
|
||||||
|
Inventories, net
|
4,633
|
3,980
|
||||||
|
Prepaid expenses and other
|
205
|
408
|
||||||
|
Total current assets of discontinued operations
|
$
|
8,157
|
$
|
8,165
|
||||
|
Property, plant and equipment, at cost, net of accumulated depreciation and amortization
|
$
|
547
|
$
|
555
|
||||
|
Investments
|
15
|
14
|
||||||
|
Deferred taxes – non-current
|
-
|
-
|
||||||
|
Total non-current assets of discontinued operations
|
$
|
562
|
$
|
569
|
||||
|
|
||||||||
|
Accounts payable – trade
|
$
|
1,004
|
$
|
949
|
||||
|
Accrued liabilities
|
974
|
1,300
|
||||||
|
Total current liabilities of discontinued operations
|
1,978
|
2,249
|
||||||
|
Deferred rent and other liabilities
|
1,387
|
1,215
|
||||||
|
Total non-current liabilities of discontinued operations
|
$
|
1,387
|
$
|
1,215
|
||||
|
|
Six months
|
Three months
|
||||||||||||||
|
|
Periods ended October 31,
|
|||||||||||||||
|
|
2017
|
2016
|
2017
|
2016
|
||||||||||||
|
Weighted average shares outstanding:
|
||||||||||||||||
|
Basic
|
8,830,486
|
8,771,494
|
8,834,945
|
8,780,633
|
||||||||||||
|
Effect of dilutive securities
|
**
|
|
**
|
|
**
|
|
**
|
|
||||||||
|
Diluted
|
8,830,486
|
8,771,494
|
8,834,945
|
8,780,633
|
||||||||||||
|
|
Six months
|
Three months
|
||||||||||||||
|
|
Periods ended October 31,
|
|||||||||||||||
|
|
2017
|
2016
|
2017
|
2016
|
||||||||||||
|
Outstanding options and SARS excluded
|
**
|
|
**
|
|
**
|
|
**
|
|
||||||||
|
|
October 31, 2017
|
April 30, 2017
|
||||||
|
|
(In thousands)
|
|||||||
|
Costs and estimated earnings in excess of billings
|
$
|
6,205
|
$
|
8,890
|
||||
|
Billings in excess of costs and estimated earnings
|
(256
|
)
|
(926
|
)
|
||||
|
Net asset
|
$
|
5,949
|
$
|
7,964
|
||||
|
|
October 31, 2017
|
April 30, 2017
|
||||||
|
|
(In thousands)
|
|||||||
|
Raw Materials and Component Parts
|
$
|
18,552
|
$
|
17,702
|
||||
|
Work in Progress
|
8,233
|
7,340
|
||||||
|
Finished Goods
|
4,425
|
4,009
|
||||||
|
|
$
|
31,210
|
$
|
29,051
|
||||
| (1) |
FEI-NY – operates out of New York and its operations consist principally of precision time and frequency control products used in three principal markets- communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations and other components and systems for the U.S. military.
|
| (2) |
FEI-Zyfer – operates out of California and its products incorporate Global Positioning System (GPS) technologies into systems and subsystems for secure communications, both government and commercial, and other locator applications. This segment also provides sales and support for the Company’s wireline telecommunications family of products, including US5G, which are sold in the United States market.
|
|
|
Six months
|
Three months
|
||||||||||||||
|
|
Periods ended October 31,
|
|||||||||||||||
|
|
2017
|
2016
|
2017
|
2016
|
||||||||||||
|
Revenues:
|
||||||||||||||||
|
FEI-NY
|
$
|
15,740
|
$
|
17,715
|
$
|
6,579
|
$
|
7,733
|
||||||||
|
FEI-Zyfer
|
7,865
|
6,596
|
3,593
|
4,249
|
||||||||||||
|
less intersegment revenues
|
(2,245
|
)
|
(1,283
|
)
|
(835
|
)
|
(516
|
)
|
||||||||
|
Consolidated revenues
|
$
|
21,360
|
$
|
23,028
|
$
|
9,337
|
$
|
11,466
|
||||||||
|
Operating loss:
|
||||||||||||||||
|
FEI-NY
|
$
|
(2,758
|
)
|
$
|
(1,887
|
)
|
$
|
(2,358
|
)
|
$
|
(1,714
|
)
|
||||
|
FEI-Zyfer
|
1,275
|
463
|
584
|
648
|
||||||||||||
|
Corporate
|
(203
|
)
|
(166
|
)
|
(92
|
)
|
(116
|
)
|
||||||||
|
Consolidated operating loss
|
$
|
(1,686
|
)
|
$
|
(1,590
|
)
|
$
|
(1,866
|
)
|
$
|
(1,182
|
)
|
||||
|
|
October 31, 2017
|
April 30, 2017
|
||||||
|
Identifiable assets:
|
||||||||
|
FEI-NY (approximately $1.6 million in China)
|
$
|
62,242
|
$
|
64,828
|
||||
|
FEI-Zyfer
|
10,663
|
10,427
|
||||||
|
less intersegment balances
|
(12,797
|
)
|
(11,992
|
)
|
||||
|
Corporate
|
52,594
|
50,056
|
||||||
|
Consolidated identifiable assets
|
$
|
112,702
|
$
|
113,319
|
||||
|
|
|
October 31, 2017
|
|
|||||||||||||
|
|
|
Cost
|
|
|
Gross Unrealized Gains
|
|
|
Gross Unrealized Losses
|
|
|
Fair Market Value
|
|
||||
|
Fixed income securities
|
|
$
|
1,316
|
|
|
$
|
79
|
|
|
$
|
-
|
|
|
$
|
1,395
|
|
|
Equity securities
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
$
|
1,316
|
|
|
$
|
79
|
|
|
$
|
-
|
|
|
$
|
1,395
|
|
|
|
|
April 30, 2017
|
|
|||||||||||||
|
|
|
Cost
|
|
|
Gross Unrealized Gains
|
|
|
Gross Unrealized Losses
|
|
|
Fair Market Value
|
|
||||
|
Fixed income securities
|
|
$
|
1,516
|
|
|
$
|
60
|
|
|
$
|
-
|
|
|
$
|
1,576
|
|
|
Equity securities
|
|
|
5,230
|
|
|
|
1,248
|
|
|
|
(239
|
)
|
|
|
6,239
|
|
|
|
|
$
|
6,746
|
|
|
$
|
1,308
|
|
|
$
|
(239
|
)
|
|
$
|
7,815
|
|
|
|
|
Less than 12 months
|
|
|
12 Months or more
|
|
|
Total
|
|
|||||||||||||||
|
|
|
Fair Value
|
|
|
Unrealized Losses
|
|
|
Fair Value
|
|
|
Unrealized Losses
|
|
|
Fair Value
|
|
|
Unrealized Losses
|
|
||||||
|
October 31, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Fixed Income Securities
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
Equity Securities
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
April 30, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed Income Securities
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
Equity Securities
|
|
|
219
|
|
|
|
(9
|
)
|
|
|
1,024
|
|
|
|
(230
|
)
|
|
|
1,243
|
|
|
|
(239
|
)
|
|
|
|
$
|
219
|
|
|
$
|
(9
|
)
|
|
$
|
1,024
|
|
|
$
|
(230
|
)
|
|
$
|
1,243
|
|
|
$
|
(239
|
)
|
|
Current
|
$
|
-
|
||
|
Due after one year through five years
|
98
|
|||
|
Due after five years through ten years
|
1,217
|
|||
|
|
$
|
1,315
|
|
|
Six months
|
Three months
|
||||||||||||||
|
|
Periods ended October 31,
|
|||||||||||||||
|
|
2017
|
2016
|
2017
|
2016
|
||||||||||||
|
Revenues
|
||||||||||||||||
|
FEI-NY
|
73.7
|
%
|
76.9
|
%
|
70.5
|
%
|
67.4
|
%
|
||||||||
|
FEI-Zyfer
|
36.8
|
28.6
|
38.5
|
37.1
|
||||||||||||
|
Less intersegment revenues
|
(10.5
|
)
|
(5.5
|
)
|
(9.0
|
)
|
(4.5
|
)
|
||||||||
|
|
100.0
|
100.0
|
100.0
|
100.0
|
||||||||||||
|
Cost of revenues
|
68.5
|
67.2
|
76.4
|
67.5
|
||||||||||||
|
Gross margin
|
31.5
|
32.8
|
23.6
|
32.5
|
||||||||||||
|
Selling and administrative expenses
|
23.6
|
24.5
|
25.0
|
24.5
|
||||||||||||
|
Research and development expenses
|
15.8
|
15.2
|
18.6
|
18.3
|
||||||||||||
|
Operating loss
|
(7.9
|
)
|
(6.9
|
)
|
(20.0
|
)
|
(10.3
|
)
|
||||||||
|
Other income(loss), net
|
5.3
|
0.9
|
(0.1
|
)
|
1.4
|
|||||||||||
|
Provision for income taxes
|
(0.5
|
)
|
(0.9
|
)
|
(6.3
|
)
|
(1.4
|
)
|
||||||||
|
(Loss) from continued operations
|
(2.1
|
)
|
(5.1
|
)
|
(13.8
|
)
|
(7.5
|
)
|
||||||||
|
(Loss) from discontinued operations, net assets
|
(1.9
|
)
|
(2.4
|
)
|
(2.1
|
)
|
(1.5
|
)
|
||||||||
|
Net (loss)
|
(4.0
|
)%
|
(7.5
|
)%
|
(15.9
|
)%
|
(9.0
|
)%
|
||||||||
|
|
Six months
|
Three months
|
||||||||||||||||||||||||||||||
|
|
Periods ended October 31,
|
|||||||||||||||||||||||||||||||
|
Segment
|
2017
|
2016
|
Change
|
2017
|
2016
|
Change
|
||||||||||||||||||||||||||
|
FEI-NY
|
$
|
15,740
|
$
|
17,715
|
$
|
(1,975
|
)
|
(11.2
|
)%
|
$
|
6,579
|
$
|
7,733
|
$
|
(1,154
|
)
|
(14.9
|
)%
|
||||||||||||||
|
FEI-Zyfer
|
7,865
|
6,596
|
1,269
|
19.2
|
3,593
|
4,249
|
(656
|
)
|
(15.4
|
)
|
||||||||||||||||||||||
|
Intersegment revenues
|
(2,245
|
)
|
(1,283
|
)
|
(962
|
)
|
75.0
|
(835
|
)
|
(516
|
)
|
(319
|
)
|
61.8
|
||||||||||||||||||
|
|
$
|
21,360
|
$
|
23,028
|
$
|
(1,668
|
)
|
(7.2
|
)%
|
$
|
9,337
|
$
|
11,466
|
$
|
(2,129
|
)
|
(18.6
|
)%
|
||||||||||||||
|
|
Six months
|
Three months
|
||||||||||||||||||||||||||||||
|
|
Periods ended October 31,
|
|||||||||||||||||||||||||||||||
|
|
2017
|
2016
|
Change
|
2017
|
2016
|
Change
|
||||||||||||||||||||||||||
|
|
$
|
6,724
|
$
|
7,554
|
$
|
(830
|
)
|
(11
|
)%
|
$
|
2,203
|
$
|
3,729
|
$
|
(1,526
|
)
|
(41
|
)%
|
||||||||||||||
|
GM Rate
|
31.5
|
% |
32.8
|
%
|
23.6
|
% |
32.5
|
%
|
||||||||||||||||||||||||
|
Six months
|
Three months
|
|||||||||||||||||||||||||||||
|
Periods ended October 31,
|
||||||||||||||||||||||||||||||
|
2017
|
2016
|
Change
|
2017
|
2016
|
Change
|
|||||||||||||||||||||||||
|
$
|
5,046
|
$
|
5,648
|
$
|
(602
|
)
|
(11
|
)%
|
$
|
2,335
|
$
|
2,816
|
$
|
(481
|
)
|
(17
|
)%
|
|||||||||||||
|
Six months
|
Three months
|
|||||||||||||||||||||||||||||
|
Periods ended October 31,
|
||||||||||||||||||||||||||||||
|
2017
|
2016
|
Change
|
2017
|
2016
|
Change
|
|||||||||||||||||||||||||
|
$
|
3,364
|
$
|
3,496
|
$
|
(132
|
)
|
(4
|
)%
|
$
|
1,734
|
$
|
2,095
|
$
|
(361
|
)
|
(17
|
)%
|
|||||||||||||
|
Six months
|
Three months
|
|||||||||||||||||||||||||||||
|
Periods ended October 31,
|
||||||||||||||||||||||||||||||
|
2017
|
2016
|
Change
|
2017
|
2016
|
Change
|
|||||||||||||||||||||||||
|
$
|
(1,686
|
)
|
$
|
(1,590
|
)
|
$
|
(96
|
)
|
6
|
%
|
$
|
(1,866
|
)
|
$
|
(1,182
|
)
|
$
|
(684
|
)
|
58
|
%
|
|||||||||
|
|
Six months
|
Three months
|
||||||||||||||||||||||||||||||
|
|
Periods ended October 31,
|
|||||||||||||||||||||||||||||||
|
|
2017
|
2016
|
Change
|
2017
|
2016
|
Change
|
||||||||||||||||||||||||||
|
Investment income
|
$
|
1,167
|
$
|
279
|
$
|
888
|
NM
|
%
|
$
|
13
|
$
|
187
|
$
|
(174
|
)
|
(93
|
)%
|
|||||||||||||||
|
Interest expense
|
(41
|
)
|
(67
|
)
|
26
|
(39
|
)%
|
(21
|
)
|
(26
|
)
|
5
|
(19
|
)%
|
||||||||||||||||||
|
Other income (expense), net
|
3
|
1
|
2
|
NM
|
%
|
1
|
-
|
1
|
NM
|
%
|
||||||||||||||||||||||
|
|
$
|
1,129
|
$
|
213
|
$
|
916
|
430
|
%
|
$
|
(7
|
)
|
$
|
161
|
$
|
(168
|
)
|
NM
|
%
|
||||||||||||||
|
|
Six months
|
Three months
|
||||||||||||||||||||||||||||||
|
|
Periods ended October 31,
|
|||||||||||||||||||||||||||||||
|
|
2017
|
2016
|
Change
|
2017
|
2016
|
Change
|
||||||||||||||||||||||||||
|
|
$
|
(98
|
)
|
$
|
(204
|
)
|
$
|
106
|
(52
|
)%
|
$
|
(584
|
)
|
$
|
(164
|
)
|
$
|
(420
|
)
|
NM
|
% | |||||||||||
|
Effective tax rate on pre-tax book income:
|
|
|||||||||||||||||||||||||||||||
|
|
17.6
|
%
|
14.8
|
%
|
31.2
|
%
|
16.1
|
%
|
|
|||||||||||||||||||||||
|
|
Six months
|
Three months
|
||||||||||||||||||||||||||||||
|
|
Periods ended October 31,
|
|||||||||||||||||||||||||||||||
|
|
2017
|
2016
|
Change
|
2017
|
2016
|
Change
|
||||||||||||||||||||||||||
|
Net Loss
|
$
|
408
|
$
|
557
|
$
|
(149
|
)
|
(27
|
)%
|
$
|
192
|
$
|
167
|
$
|
25
|
15
|
%
|
|||||||||||||||
|
31.1 -
|
|
|
|
|
|
31.2 -
|
|
|
|
|
|
32 -
|
|
|
|
|
|
101-
|
The following materials from the Frequency Electronics, Inc. Quarterly Report on Form 10-Q for the quarter ended October 31, 2017 formatted in eXtensible Business Reporting Language (XBRL): (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Operations and Comprehensive Loss, (iii) Condensed Consolidated Statements of Cash Flows and (iv) Notes to Condensed Consolidated Financial Statements.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|